Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
11/2010
11/03/2010CN101874826A Granulose rabdosia rubescens compound preparation and preparation method thereof
11/03/2010CN101874824A Active extract containing trilobatin and application thereof
11/03/2010CN101874817A Brucea javanica oil enteric-coated microcapsule, preparation method and application thereof
11/03/2010CN101874815A Compound nutritional tricholoma matsutake capsule
11/03/2010CN101874807A Application of lanosterol and tuckahoe extract in treating cachexia
11/03/2010CN101874803A Slow-release injection containing vasoinhibitor and synergistic agent thereof
11/03/2010CN101874793A Vorinostat solid preparation
11/03/2010CN101874788A 7-ethyl-10-hydroxycamptothecine liposome freeze-dried powder injection and preparation method thereof
11/03/2010CN101874779A Fructose diphosphate sodium liposome solid preparation and novel application thereof
11/03/2010CN101456845B 4,5-diaryl-2-sulfhydryl miazines compounds and synthetic method thereof and pharmaceutical use
11/03/2010CN101371839B Novel use of bisbenzylisoquinoline alkaloids
11/03/2010CN101371838B Novel uses of neferine and analogue thereof
11/03/2010CN101348514B Use of starfish saponin compound extracted from Culcita novaeguineae
11/03/2010CN101343274B Carbazoles alkaloid, preparation and application thereof
11/03/2010CN101317965B Traditional Chinese medicinal preparation for treating cancer
11/03/2010CN101280004B Polypeptide ERC(N5) for specific inhibition of tumor cell and tumor angiogenic blood vessel
11/03/2010CN101260153B Human breast carcinoma tissue antigen, and coding gene, preparation method and application thereof
11/03/2010CN101249235B Chinese medicine for curing esophagus cancer and method of preparing the same
11/03/2010CN101239106B Pharmaceutical formulation with anticancer function
11/03/2010CN101235102B Method for preparing folic acid coupling hydroxypropyl chitosan nano particles
11/03/2010CN101230068B Application of polyether triterpene compound in preparing medicine for treating tumour
11/03/2010CN101203224B Use of pyrimidylaminobenzamides for the treatment of diseases that respond to modulation of Tie-2 kinase activity
11/03/2010CN101199509B Function of 2',2'-CH3-2'H,4H-3,6'-two benzopyran-4-ketone in preparing medicine for treating cancer
11/03/2010CN101137609B Desmosdumotin, its production method and application against tumour and AIDS
11/03/2010CN101130081B Use of PNAS-4 gene in preparing antineoplastic and antineoplastic auxiliary medicament
11/03/2010CN101115760B Pyrrolopyrazoles, potent kinase inhibitors
11/03/2010CN101098870B Novel fused imidazole derivative
11/02/2010USRE41911 Epothilone derivatives
11/02/2010US7825255 Adenosine receptor selective modulators
11/02/2010US7825247 an N-phenyl-4-(4-methyl-piperazin-1-ylmethyl)-benzamide claimed intermediate easily prepared by amidation of the aniline and the benzoic acid; reaction with a 2-aminopyrimidine to produce antitumor tyrosine kinase inhibitor
11/02/2010US7825242 Immunosuppressants; autoimmune diseases; antiinflammatory agents;antiarthritic agents; aids
11/02/2010US7825219 Binding protein; therapy for bone tumors
11/02/2010US7825216 Phenylanine derivatives
11/02/2010US7825146 Sulfonamide derivative having isoxazole ring
11/02/2010US7825140 3,4-disubstituted 1H-pyrazole compounds and their use as cyclin dependent kinase and glycogen synthase kinase-3 modulators
11/02/2010US7825129 Thieno[2,3-c] isoquinolines for use as inhibitors of PARP
11/02/2010US7825128 such as N-(ethoxycarbonyl)-S-(4-{[4-{[(R)-2-hydroxy-1-methylethyl]amino}-5-(2-thienyl)pyrimidine-2-yl]amino}phenyl)-S-methylsulfoximide, used for the treatment of breast cancer and rheumatoid arthritis
11/02/2010US7825114 Substituted aminopyrazolopyridines and salts thereof, pharmaceutical compositions comprising same, methods of preparing same and uses of same
11/02/2010US7825105 such as 3,10-Dibenzyloxyminocycline, used to treat bacterial infections and neoplasms, as well as blocking tetracycline efflux and modulation of gene expression
11/02/2010US7825094 the sensitivity of cells typical of various proliferative disorders to the ansamycin CNF-101 ("17-AAG") is proportional to the HER-2 levels in those cells
11/02/2010US7824696 Modified nucleotides for immunotherapy; induce immunology response; consisting of nucleoside methylphosphonate and 2'-O-methyl-ribonucleoside groups
11/02/2010US7824683 Methods for augmenting an immune response using anti-CD40 antibodies
11/02/2010CA2545527C Pyrazole derivatives as inhibitors of receptor tyrosyne kinases
11/02/2010CA2497544C Pyrazolo[1,5-a]pyrimidines compounds as cyclin dependent kinase inhibitors
11/02/2010CA2485201C Camptothecins with a modified lactone ring
11/02/2010CA2471521C Novel microsphere and method for production thereof
11/02/2010CA2462799C Pyrimidine derivatives
11/02/2010CA2460121C 3-substituted-4-pyrimidone derivatives
11/02/2010CA2455416C Vinca alcaloids preparations process and their derivatives
11/02/2010CA2437715C Carboline derivatives
11/02/2010CA2413971C Heterocyclic hydrazones as novel anti-cancer agents
11/02/2010CA2407466C Formulations and methods of using nitric oxide mimetics against a malignant cell phenotype
11/02/2010CA2311456C Imidazonaphthyridines and their use in inducing cytokine biosynthesis
10/2010
10/28/2010WO2010124283A2 Methods and compositions relating to hematologic malignancies
10/28/2010WO2010124004A2 Nanocarrier therapy for treating invasive tumors
10/28/2010WO2010123931A1 Methods of treatment for solid tumors
10/28/2010WO2010123591A2 Small molecule inhibitors of nads, namnat, and nmnat
10/28/2010WO2010123583A2 1-aryl or 1-heteroaryl-pyrido[b]indoles and uses thereof
10/28/2010WO2010123545A2 Angiogenesis inhibitors
10/28/2010WO2010123156A1 Angiogenesis inhibitor
10/28/2010WO2010123139A1 Arylcarboxamide derivative having sulfamoyl group
10/28/2010WO2010123078A1 Method for predicting therapeutic effect of chemotherapy on renal cell cancer
10/28/2010WO2010123065A1 Cancer antigen helper peptide
10/28/2010WO2010123049A1 Selective ep4 receptor agonistic substance for treatment of cancer
10/28/2010WO2010123037A1 Agent for regulating composition ratio of intestinal bacterial flora
10/28/2010WO2010123012A1 Antibody containing igg2 having amino acid mutation introduced therein
10/28/2010WO2010122961A1 Method for preparing cell pharmaceutical
10/28/2010WO2010122945A1 Method for preparing human t cell population having both cytotoxic and immunosuppressive activities
10/28/2010WO2010122294A1 Thiophene inhibitors of ikk-b serine-threonine protein kinase
10/28/2010WO2010122275A1 Pharmaceutical preparation
10/28/2010WO2010122272A1 1-pyrazolo[4,3-c]isoquinoline derivatives, preparation thereof and therapeutic use thereof
10/28/2010WO2010122217A1 A novel cell and therapeutical and diagnostical methods based thereon
10/28/2010WO2010122204A1 Polyarginine nanocapsules
10/28/2010WO2010122171A1 5-heteroarylmethyl-i- (b-mercapto- [1,2, 4 -triazolylmethyl) -cyclopentanol as fungicides
10/28/2010WO2010122170A1 5-mercapto- [1,2,4] triazolylmethyl-cyclopentanol compounds and their agricultural and pharmaceuti al uses
10/28/2010WO2010122169A1 5-mercapto- [1,2, 4] triazole compounds and their agricultural and pharmaceutical uses
10/28/2010WO2010122167A1 5 -mercapto- [1, 2, 4] triazolylmethyl-cyclopentanol compounds and their agricultural and pharmaceutical uses
10/28/2010WO2010122109A1 Method for the treatment of acute myeloid leukemia
10/28/2010WO2010122091A1 Thia-triaza-as-indacenes as pi3-kinases inhibitors for the treatment of cancer
10/28/2010WO2010122071A1 Thia-triaza-cyclopentazulenes as pi3-kinases inhibitors for the treatment of cancer
10/28/2010WO2010122069A1 5-alkynyl-pyridines
10/28/2010WO2010121995A1 3,3'-spiroindolinone derivatives and their use for cancer
10/28/2010WO2010121963A1 Resorcinol derivatives as hsp90 inhibitors
10/28/2010WO2010121646A1 Heterocyclic compounds as mek inhibitors
10/28/2010WO2010121575A1 Oxalato complexes of platinum
10/28/2010WO2010121570A1 Methyl cantharimide compounds, treatment method using them and their preparation method
10/28/2010WO2010121487A1 Preparation and use of novel antibiotic, anticancer compounds and derivatives thereof
10/28/2010WO2010121486A1 Prodrugs based on gemcitabine structure as well as synthetic method and application thereof
10/28/2010WO2010121455A1 A drug composition for treating tumor with polymeric micelle encapsulating antineoplastic
10/28/2010WO2010121379A1 Treatment of ovarian cancer using an anticancer agent conjugated to an angiopep-2 analog
10/28/2010WO2010121368A1 Compositions comprising a radiosensitizer and an anti-cancer agent and methods of uses thereof
10/28/2010WO2010068815A3 Compositions and methods for treating cellular proliferative disorders
10/28/2010WO2009141090A8 {f-19} -labeled l-glutamic acid and l-glutamine derivative (iii), use thereof and method for obtaining them
10/28/2010WO2009114814A3 Therapeutic substances that modulate genome methylation
10/28/2010US20100273891 Isoflavone metabolites
10/28/2010US20100273889 Use of a beta blocker for the manufacture of a medicament for the treatment of hemangiomas
10/28/2010US20100273872 Use of 4-oxobutanoic acid derivatives in the treatment of pathologies associated with immunological disorders
10/28/2010US20100273871 Anticancer tocopheryl succinate derivatives
10/28/2010US20100273869 Anti-cancer tocotrienol analogues and associated methods
10/28/2010US20100273868 R-Zileuton for Use in Conditions Associated with Increased 5-Lipoxygenase and/or Leukotriene Activity (EG Asthma)
1 ... 618 619 620 621 622 623 624 625 626 627 628 629 630 631 632 633 634 635 636 637 638 ... 2211